- Lean non-alcoholic fatty liver disease: Is there a place for novel antidiabetics in the therapeutic management of this underappreciated “enemy”?
-
Patoulias D, Doumas M
- KMID: 2507977
- Clin Mol Hepatol.
- 2020 Oct;26(4):582-583.
- doi: 10.3350/cmh.2020.0264
-
- CITED
-
- Close
- SHARE
-
- Close
- Letter: Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naïve Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019:43:711–7)
-
Patoulias , Doumas M
- KMID: 2466511
- Diabetes Metab J.
- 2019 Dec;43(6):906-908.
- doi: 10.4093/dmj.2019.0107
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular disease
-
Patoulias , Imprialos , Stavropoulos K, Doumas M
- KMID: 2459795
- Clin Mol Hepatol.
- 2019 Sep;25(3):331-332.
- doi: 10.3350/cmh.2019.0034
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Dipeptidyl Peptidase-4 Inhibitors and COVID-19-Related Deaths among Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Observational Studies
-
Patoulias D, Doumas M
- KMID: 2519678
- Endocrinol Metab.
- 2021 Aug;36(4):904-908.
- doi: 10.3803/EnM.2021.1048
The coronavirus disease 2019 (COVID-19) pandemic remains an unbeaten enemy. Unfortunately, no targeted treatment option is available. Patients with type 2 diabetes mellitus (T2DM) have increased odds for severe or... -
- CITED
-
- Close
- SHARE
-
- Close
- Cardiovascular Outcomes with Finerenone According to Glycemic Status at Baseline and Prior Treatment with Newer Antidiabetics among Patients with Type 2 Diabetes Mellitus
-
Patoulias D, Papadopoulos C, Karagiannis A, Vassilikos V, Doumas M
- KMID: 2527147
- Endocrinol Metab.
- 2022 Feb;37(1):170-174.
- doi: 10.3803/EnM.2021.1296
Type 2 diabetes mellitus (T2DM) and cardiovascular disease are closely interconnected. We sought to determine the cardioprotective action of finerenone according to prior treatment with newer antidiabetics and glycemic status.... -
- CITED
-
- Close
- SHARE
-
- Close
